Montreal, Canada

Karl St-Arnaud

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karl St-Arnaud. Retrieved from https://idiyas.com/inventor/karl-st-arnaud

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Karl St-Arnaud - Innovative Inventor from Montreal

Introduction: Karl St-Arnaud is a renowned inventor based in Montreal, Canada, known for his groundbreaking contributions to various industries through his innovative creations.

Latest Patents: Karl St-Arnaud holds several patents in the fields of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise and interests.

Career Highlights: With a career spanning over two decades, Karl St-Arnaud has established himself as a leading figure in the Canadian innovation scene, with numerous successful inventions that have had a significant impact on society.

Collaborations: Throughout his career, Karl St-Arnaud has collaborated with top research institutions, universities, and companies to further develop and commercialize his inventions, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Karl St-Arnaud's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of inventions, with a legacy that will continue to inspire future generations of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…